Is SCHD a Good ETF to Buy?
With around $65.7 billion in net assets, Schwab’s US Dividend…
Buy
75
ALIZY Quote, Financials, Valuation and Earnings
Last price:
$30.93
Seasonality move
:
6.32%
Day range:
$30.90 - $31.16
52-week range:
$26.05 - $33.19
Dividend yield:
4.81%
P/E ratio:
11.75x
P/S ratio:
1.01x
P/B ratio:
1.85x
Volume:
174.4K
Avg. volume:
132.8K
1-year change:
16.32%
Market cap:
$119.5B
Revenue:
$111.5B
EPS (TTM):
$2.63
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $126.5B | $128.2B | $140.7B | $65.3B | $111.5B | |
| Revenue Growth (YoY) | 4.07% | 1.33% | 9.76% | -53.57% | 70.72% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $9B | $9.5B | $14.8B | -- | -- | |
| Other Inc / (Exp) | $1.9B | -$4.7B | $6.6B | $3.9B | -$2.1B | |
| Operating Expenses | $8.6B | $8.7B | $14.3B | -$737.2M | $10.8M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $1.2B | $1.1B | $1.4B | -- | -- | |
| EBT. Incl. Unusual Items | $12.4B | $11B | $11.3B | $10.2B | $12.5B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $3.1B | $2.8B | $2.9B | $3B | $2.8B | |
| Net Income to Company | $9.3B | $8.1B | $8.4B | $7.2B | $9.8B | |
| Minority Interest in Earnings | -$433.2M | -$372.3M | -$585.7M | -$458.7M | -$531.6M | |
| Net Income to Common Excl Extra Items | $8.9B | $7.8B | $7.8B | $6.8B | $9.2B | |
| Basic EPS (Cont. Ops) | $2.12 | $1.88 | $1.89 | $1.64 | $2.30 | |
| Diluted EPS (Cont. Ops) | $2.11 | $1.86 | $1.87 | $1.63 | $2.29 | |
| Weighted Average Basic Share | $4.2B | $4.1B | $4.1B | $4B | $4B | |
| Weighted Average Diluted Share | $4.2B | $4.1B | $4.1B | $4.1B | $4B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $13.6B | $12.1B | $12.6B | $10.2B | $12.5B | |
| Revenue (Reported) | $126.5B | $128.2B | $140.7B | $65.3B | $111.5B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $13.6B | $12.1B | $12.6B | $10.2B | $12.5B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $32.4B | $33.9B | $26.2B | $27.5B | $39B | |
| Revenue Growth (YoY) | 5.67% | 4.71% | -22.83% | 5.1% | 41.72% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -$11.1M | $180.7M | $323.3M | |
| Operating Expenses | -$164.9M | -$153.3M | $1.5B | $1.6B | $1.5B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $214M | $165.1M | $152.1M | $179.6M | $211.2M | |
| EBT. Incl. Unusual Items | $3.4B | $3.5B | $4.1B | $3.1B | $3.9B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $882.9M | $848.9M | $1.1B | $732.8M | $1B | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$79.5M | -$140.3M | -$137M | -$117.6M | -$155.1M | |
| Net Income to Common Excl Extra Items | $2.4B | $2.5B | $2.9B | $2.2B | $2.7B | |
| Basic EPS (Cont. Ops) | $0.58 | $0.60 | $0.72 | $0.56 | $0.70 | |
| Diluted EPS (Cont. Ops) | $0.58 | $0.60 | $0.71 | $0.56 | $0.70 | |
| Weighted Average Basic Share | $4.1B | $4.1B | $4B | $4B | $3.9B | |
| Weighted Average Diluted Share | $4.1B | $4.1B | $4B | $4B | $3.9B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $3.6B | $3.6B | $4.2B | $3.2B | $4.1B | |
| Revenue (Reported) | $32.4B | $33.9B | $26.2B | $27.5B | $39B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $3.6B | $3.6B | $4.2B | $3.2B | $4.1B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $97.4B | $140.9B | $101.3B | $77.9B | $120B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -$582.6M | -$1.1B | $2.7B | -$1.1B | -$134.7M | |
| Operating Expenses | -- | -$488.2M | $4.7B | $3.9B | -$4.1B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $755.1M | $1.1B | $1.1B | $495.7M | $409.9M | |
| EBT. Incl. Unusual Items | $13.2B | $14.5B | $8.2B | $11.8B | $14.5B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $3.6B | $2.5B | $3B | $3.5B | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$376.5M | -$540.5M | -$526.1M | -$508.6M | -$598M | |
| Net Income to Common Excl Extra Items | $7.7B | $10.4B | $5.2B | $8.2B | $10.4B | |
| Basic EPS (Cont. Ops) | $1.85 | $2.53 | $1.27 | $2.08 | $2.64 | |
| Diluted EPS (Cont. Ops) | $1.85 | $2.52 | $1.24 | $2.07 | $2.63 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $13.9B | $15.7B | $9.3B | $12.3B | $14.9B | |
| Revenue (Reported) | $97.4B | $140.9B | $101.3B | $77.9B | $120B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $13.9B | $15.7B | $9.3B | $12.3B | $14.9B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $90.7B | $103.1B | $63.8B | $94.8B | $103.2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -$582.6M | $3.2B | -$647.2M | $241.2M | $2.2B | |
| Operating Expenses | -$538.8M | -$254.5M | $4.9B | $5.8B | $1.7B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $755.1M | $749.6M | $440.8M | $495.7M | $409.9M | |
| EBT. Incl. Unusual Items | $7.9B | $11.4B | $8.3B | $9.5B | $11.4B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2B | $2.7B | $2.4B | $2.1B | $2.8B | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$271.3M | -$440.4M | -$380.9M | -$418.6M | -$485M | |
| Net Income to Common Excl Extra Items | $5.6B | $8.3B | $5.5B | $6.9B | $8.1B | |
| Basic EPS (Cont. Ops) | $1.35 | $2.01 | $1.36 | $1.74 | $2.04 | |
| Diluted EPS (Cont. Ops) | $1.35 | $2.01 | $1.35 | $1.73 | $2.04 | |
| Weighted Average Basic Share | $8.3B | $8.2B | $8.1B | $8B | $11.7B | |
| Weighted Average Diluted Share | $8.3B | $8.2B | $8.1B | $8B | $11.7B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $8.7B | $12.2B | $8.7B | $10B | $11.8B | |
| Revenue (Reported) | $90.7B | $103.1B | $63.8B | $94.8B | $103.2B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $8.7B | $12.2B | $8.7B | $10B | $11.8B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $20.7B | $24.3B | $27.5B | $21.6B | $23.8B | |
| Short Term Investments | $667.3B | $767B | -- | $584.3B | $622B | |
| Accounts Receivable, Net | $23.2B | $25.5B | -- | $7.6B | $8.8B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $2.8B | $3.2B | -- | $987.7M | $871.1M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $725.5B | $832.6B | $27.5B | $619.8B | $661.5B | |
| Property Plant And Equipment | $14B | $15.2B | -- | $13.7B | $14.4B | |
| Long-Term Investments | $700.9B | $815.5B | $948.7B | $710.7B | $768.3B | |
| Goodwill | $14.8B | $16.6B | -- | $17.4B | $18.4B | |
| Other Intangibles | $1.8B | $2.6B | $20.6B | $2.3B | $2.2B | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $1.1T | $1.3T | $1.2T | $1T | $1.1T | |
| Accounts Payable | $10.4B | $11.9B | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $15.7B | $17.6B | -- | $5B | $5.8B | |
| Long-Term Debt | $35.1B | $40.3B | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1T | $1.2T | $1.2T | $940.7B | $1T | |
| Common Stock | $1.3B | $1.4B | -- | $1.3B | $1.3B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $82.9B | $99.4B | $69.2B | $58.4B | $64.6B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $3.8B | $4.6B | $4.8B | $4.6B | $5.6B | |
| Total Equity | $86.7B | $104B | $74B | $63B | $70.3B | |
| Total Liabilities and Equity | $1.1T | $1.3T | $1.2T | $1T | $1.1T | |
| Cash and Short Terms | $688B | $791.3B | $27.5B | $605.9B | $645.8B | |
| Total Debt | $35.1B | $40.3B | -- | -- | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $25.4B | $25.4B | $26.4B | $25.6B | $34.6B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $25.4B | $25.4B | $26.4B | $25.6B | $34.6B | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | $770.9B | $790.3B | $557.1B | $733.6B | $828.7B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $17.3B | $18.3B | $18.9B | $19.8B | $21B | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $1.2T | $1.3T | $1T | $997.8B | $1.1T | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | -- | -- | |
| Long-Term Debt | $44.8B | $42B | $40.2B | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.1T | $1.2T | $976.2B | $933.6B | $1.1T | |
| Common Stock | -- | -- | -- | $1.2B | $1.3B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $3.8B | $4.3B | $3.8B | $4.9B | $4B | |
| Total Equity | $91.5B | $99B | $54.8B | $64.2B | $68.6B | |
| Total Liabilities and Equity | $1.2T | $1.3T | $1T | $997.8B | $1.1T | |
| Cash and Short Terms | $25.4B | $25.4B | $26.4B | $25.6B | $34.6B | |
| Total Debt | $44.8B | $42B | $40.2B | -- | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $9.3B | $8.1B | $8.4B | $7.2B | $9.8B | |
| Depreciation & Amoritzation | $2.3B | $2.6B | $3B | $2.3B | $2.5B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $40.8B | $36.6B | $29.7B | $18.9B | $26.5B | |
| Capital Expenditures | $1.5B | $1.7B | $1.7B | $1.7B | $2.3B | |
| Cash Acquisitions | -$1B | -$1.5B | -$4.4B | -$1.4B | -$928.9M | |
| Cash From Investing | -$31B | -$33B | -$23.4B | -$15.8B | -$13B | |
| Dividends Paid (Ex Special Dividend) | -$4.5B | -$4.7B | -$5.1B | -$5.1B | -$5.3B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $7.7B | $7.3B | $7.2B | $9.3B | $7.4B | |
| Long-Term Debt Repaid | -$6.6B | -$5.3B | -$7.5B | -$6.8B | -$6.1B | |
| Repurchase of Common Stock | -- | -$76.5M | -- | -$1.4B | -$2.4B | |
| Other Financing Activities | -$1.5B | -$917M | -$1.4B | -$109.7M | $606.3M | |
| Cash From Financing | -$5.4B | -$1.6B | -$4.5B | -$4.6B | -$6.2B | |
| Beginning Cash (CF) | $19.3B | $24.5B | $26.6B | $25.3B | $24.8B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $4.4B | $2B | $1.8B | -$1.5B | $7.3B | |
| Ending Cash (CF) | $23.6B | $25.6B | $28.6B | $24.1B | $31.6B | |
| Levered Free Cash Flow | $39.3B | $34.9B | $28.1B | $17.2B | $24.2B | |
| Period Ending | 2011-12-31 | 2012-12-31 | 2013-12-31 | 2014-12-31 | 2015-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | $1.8B | $1.8B | $1.7B | |
| Depreciation & Amoritzation | -- | -- | $401.8M | $367.1M | $374.5M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | $4.3B | $7.8B | $4.6B | |
| Capital Expenditures | -- | -- | $559.2M | $714.1M | $573.5M | |
| Cash Acquisitions | -- | -- | -$74.9M | -$1.2B | -$223.9M | |
| Cash From Investing | -- | -- | -$10B | -$5.1B | -$4.1B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -$36.4M | -$101.3M | -$68.9M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $3.7B | $606M | $1.6B | |
| Long-Term Debt Repaid | -- | -- | -$314.3M | -$636M | -$1.1B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$66.5M | $120.4M | $94.6M | |
| Cash From Financing | -- | -- | $3.4B | $54.3M | $589.2M | |
| Beginning Cash (CF) | -- | -- | $17.3B | $15.4B | $15.1B | |
| Foreign Exchange Rate Adjustment | -- | -- | -$105.3M | $223.8M | $215.8M | |
| Additions / Reductions | -- | -- | -$2.4B | $2.7B | $1.1B | |
| Ending Cash (CF) | -- | -- | $14.9B | $18.4B | $16.5B | |
| Levered Free Cash Flow | -- | -- | $3.7B | $7.1B | $4B | |
| Period Ending | 2012-09-30 | 2013-09-30 | 2014-09-30 | 2015-09-30 | 2016-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | $8.8B | $7.9B | -- | |
| Depreciation & Amoritzation | -- | -- | $1.6B | $1.5B | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | $39.3B | $29.5B | -- | |
| Capital Expenditures | -- | $1.4B | $2.1B | $2.4B | $573.5M | |
| Cash Acquisitions | -- | -$938.5M | $82.8M | -$1.3B | -$223.9M | |
| Cash From Investing | -- | -- | -$40.7B | -$23.7B | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -$3B | -$3.5B | -$3.8B | -$68.9M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $8.2B | $5.2B | -- | |
| Long-Term Debt Repaid | -- | -- | -$5.4B | -$5.1B | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$246.7M | -$37.4M | -- | |
| Cash From Financing | -- | -- | -$930.7M | -$3.7B | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -$2.3B | $2.1B | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | $37.2B | $27.1B | -- | |
| Period Ending | 2021-01-08 | 2022-01-08 | 2023-01-08 | 2024-01-08 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get ALIZY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ALIZY
Sector
P/E ratio
11.75x
11.84x
PEG ratio
0.43x
0.36x
P/B ratio
1.85x
1.04x
Price / LTM sales
1.01x
2.55x
Growth Metrics
ALIZY
Sector
Revenue growth
41.72%
5.96%
Earnings growth
26.37%
6.39%
Revenue (5-year growth)
-1.71%
5.82%
Earnings forecast
$0.60
$0.59
Profitability
ALIZY
Sector
Profitability FY 2024
--
$172.6M
Return on invested capital
13.67%
5.23%
Return on assets
0.97%
0.97%
Return on equity
15.58%
9.37%
Earnings Date
Last Earnings Date
Nov
13
Next Earnings Date
Feb
28
Estimated Next Earnings Date
Feb
12
Balance Sheet
ALIZY
Sector
Total cash
$34.6B
$592.8M
Short term investments
$622B
$406.3M
Total assets
$1.1T
$4.4B
Long term debt
--
$261.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is NAIL a Good ETF to Buy?
If you’re thinking about buying the NAIL ETF, this article…
3 High Dividend Dow Jones Stocks
Thanks to surging stock prices over the past two years,…
Stock Ideas
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 36x
Alerts
Buy
57
NARI alert for Jan 8
Inari Medical [NARI] is up 0.06% over the past day.
Buy
69
UNF alert for Jan 8
UniFirst [UNF] is down 0.53% over the past day.
Sell
31
APOG alert for Jan 8
Apogee Enterprises [APOG] is down 6.25% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
